Bide Pharmaceutical (688073.SH) released its 2023 annual performance report. The company achieved operating income of 1 during the reporting period...
According to Zhitong Finance App News, Bide Pharmaceutical (688073.SH) released its 2023 annual performance report. During the reporting period, the company achieved operating income of 1,092 million yuan, an increase of 30.94%; net profit attributable to shareholders of listed companies was 110 million yuan, a year-on-year decrease of 24.94%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 123 million yuan, a decrease of 10.57% year on year; basic income per share was 1.21 yuan. The company plans to distribute a cash dividend of 9 yuan (tax included) to all shareholders for every 10 shares.